Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Pneumococcal disease
Older adults
Risk group
2022
Clear all
Type of publications
NITAG documentation
(1)
Systematic reviews (SYSVAC)
(194)
Topics
Available to download in languages
Regions
Africa
(2)
Americas
(3)
Eastern Mediterranean
(1)
Europe
(2)
South-East Asia
(2)
Western Pacific
(3)
Countries
Diseases
COVID-19
(188)
Pneumococcal disease
(7)
Herpes zoster
(4)
HIV / AIDS
(1)
Human papillomavirus (HPV)
(5)
Influenza
(17)
Yellow fever
(2)
Vaccine topics
Acceptance
(15)
Administration
(30)
Coverage
(1)
Economic aspects
(1)
Efficacy/effectiveness
(68)
Ethical issues
(1)
Safety
(105)
Target population
Older adults
(194)
Risk group
(1)
Adolescents
(103)
Adults
(250)
All age groups
(225)
Children
(46)
Healthcare workers
(75)
Newborn
(22)
Parents/caregivers
(18)
Pregnant women
(45)
Travellers
(1)
Publication date
2022
(195)
2024
(1)
2023
(64)
2021
(109)
2020
(60)
2019
(3)
2018
(3)
2017
(5)
2016
(6)
2015
(3)
2014
(1)
2012
(3)
195 results found
2022
∙
Tsai, Y. T. Ku, H. C. Maithreepala, S. D. Tsai, Y. J. Chen, L. F. Ko, N. Y. Konara Mudiyanselage, S. P.
Higher Risk of Acute Respiratory Distress Syndrome and Risk Factors among Patients with COVID-19: A Systematic Review, Meta-Analysis and Meta-Regression
2022
∙
Favara, G. Barchitta, M. Maugeri, A. Faro, G. Agodi, A.
HIV infection does not affect the risk of death of COVID-19 patients: A systematic review and meta-analysis of epidemiological studies
2022
∙
Meshram, H. S. Kute, V. Rane, H. Dave, R. Banerjee, S. Mishra, V. Chauhan, S.
Humoral and cellular response of COVID-19 vaccine among solid organ transplant recipients: A systematic review and meta-analysis
2022
∙
Bailey, A. J. M. Maganti, H. B. Cheng, W. Shorr, R. Arianne Buchan, C. Allan, D. S.
Humoral and Cellular Response of Transplant Recipients to a Third Dose of mRNA SARS-CoV-2 Vaccine: A Systematic Review and Meta-analysis
2022
∙
Yoo, J. J. Yon, D. K. Lee, S. W. Shin, J. I. Kim, B. K.
Humoral Immunogenicity to SARS-CoV-2 Vaccination in Liver Transplant Recipients: A Systematic Review and Meta-Analysis
2022
∙
D'Elia, L. Giaquinto, A. Zarrella, A. F. Rendina, D. Iaccarino Idelson, P. Strazzullo, P. Galletti, F.
Hypertension and mortality in SARS-COV-2 infection: A meta-analysis of observational studies after 2 years of pandemic
2022
∙
Martins-Branco, D. Nader-Marta, G. Tecic Vuger, A. Debien, V. Ameye, L. Brandão, M. Punie, K. Loizidou, A. Willard-Gallo, K. Spilleboudt, C. Awada, A. Piccart, M. de Azambuja, E.
Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis
2022
∙
Müller, K. E. Dohos, D. Sipos, Z. Kiss, S. Dembrovszky, F. Kovács, N. Solymár, M. Erőss, B. Hegyi, P. Sarlós, P.
Immune response to influenza and pneumococcal vaccines in adults with inflammatory bowel disease: A systematic review and meta-analysis of 1429 patients
2022
∙
Shoar, S. Prada-Ruiz, A. C. C. Patarroyo-Aponte, G. Chaudhary, A. Sadegh Asadi, M.
Immune Response to SARS-CoV-2 Vaccine among Heart Transplant Recipients: A Systematic Review
2022
∙
ElSawi, H. A. Elborollosy, A.
Immune-mediated adverse events post-COVID vaccination and types of vaccines: a systematic review and meta-analysis
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register